Synonyms: Rova-T | SC0001-SCX
Compound class:
Antibody
Comment: Rovalpituzumab tesirine is an antibody-drug conjugate (ADC) that was designed to exploit the expression of the NOTCH ligand DLL3 on certain tumours for anti-cancer efficacy [1]. It is a humanized anti-DLL3 monoclonal that is linked to a pyrrolobenzodiazepine dimer toxin called tesirine (or D6.5; PubChem CID 73672523). Once the ADC is internalized, its D6.5 payload is released and causes lethal DNA damage in the target cells.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
10141 | rovalpituzumab tesirine |
Synonyms ![]() |
Rova-T | SC0001-SCX |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 569 |
Other databases | |
GtoPdb PubChem SID | 404859008 |
Search PubMed clinical trials | rovalpituzumab tesirine |
Search PubMed titles | rovalpituzumab tesirine |
Search PubMed titles/abstracts | rovalpituzumab tesirine |